Disposition of hop prenylflavonoids in human breast tissue

Molecular Nutrition and Food Research

Volumn 54, Issue SUPPL. 2, 2010, Pages

  Bolca, Selin ^a   Li, Jinghu ^b   Nikolic, Dejan ^b   Roche, Nathalie ^c   Blondeel, Phillip ^c   Possemiers, Sam ^a   De Keukeleire, Denis ^a   Bracke, Marc ^c   Heyerick, Arne ^a   Van Breemen, Richard B ^b   Depypere, Herman ^c  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

17 estradiol; 8 prenylnaringenin; Bioavailability; Breast tissue; Humulus lupulus

Indexed keywords

8 PRENYLNARINGENIN; 8-PRENYLNARINGENIN; FLAVANONE DERIVATIVE; FLAVONOID; ISOXANTHOHUMOL; PHYTOESTROGEN; PROPIOPHENONE DERIVATIVE; XANTHOHUMOL; XANTHONE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BIOTRANSFORMATION; BLOOD; BREAST; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FLOWER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMULUS; MAMMARY GLAND; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TANDEM MASS SPECTROMETRY; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ADOLESCENT; ADULT; BIOTRANSFORMATION; BREAST; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETARY SUPPLEMENTS; FEMALE; FLAVANONES; FLAVONOIDS; FLOWERS; HUMANS; HUMULUS; MAMMARY GLANDS, HUMAN; MIDDLE AGED; PHYTOESTROGENS; PROPIOPHENONES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; XANTHONES; YOUNG ADULT;

HUMULUS; HUMULUS LUPULUS;

EID: 78649867931     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900519     Document Type: Article

References (64)

1. Metzler, M., Editorial - hormonally active compounds in food. Mol. Nutr. Food Res. 2007, 51, 763.
2. Eisenbrand, G., Isoflavones as phytoestrogens in food supplements and dietary foods for special medical purposes. Mol. Nutr. Food Res. 2007, 51, 1305-1312.
3. Eisenbrand, G., Untitled - Answer to Dr. Messina's letter to the Editor. Mol. Nutr. Food Res. 2008, 52, 737-738.
4. Messina, M., Conclusion that isoflavones exert estrogenic effects on breast tissue and may raise breast cancer risk unfounded. Mol. Nutr. Food Res. 2008, 52, 299-300.
5. Rimoldi, G., Christoffel, J., Wuttke, W., Morphologic changes induced by oral long-term treatment with 8-prenylnaringenin in the uterus, vagina, and mammary gland of castrated rats. Menopause 2006, 13, 669-677.
6. Messina, M., Wu, A. H., Perspectives on the soy-breast cancer relation. Am. J. Clin. Nutr. 2009, 89, S1673-S1679.
7. Stubert, J., Gerber, B., Isoflavones - mechanism of action and impact on breast cancer risk. Breast Care 2009, 4, 22-29.
8. Stevens, J. F., Taylor, A. W., Deinzer, M. L., Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1999, 832, 97-107.
9. Coldham, N. G., Sauer, M. J., Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement. Food Chem. Toxicol. 2001, 39, 1211-1224.
10. Heyerick, A., Vervarcke, S., Depypere, H., Bracke, M., De Keukeleire, D., A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 2006, 54, 164-175.
11. Milligan, S. R., Kalita, J. C., Heyerick, A., Rong, H. et al., Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J. Clin. Endocrinol. Metab. 1999, 83, 2249-2252.
12. Hümpel, M., Isaksson, P., Schaefer, O., Kaufmann, U. et al., Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus. J. Steroid Biochem. Mol. Biol. 2005, 97, 299-305.
13. Guo, J., Nikolic, D., Chadwick, L. R., Pauli, G. F., van Breemen, R. B., Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol form hops (Humulus lupulus L.). Drug Metab. Dispos. 2006, 34, 1152-1159.
14. Nikolic, D., Li, Y., Chadwick, L. R., Pauli, G., van Breemen, R. B., Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes. J. Mass Spectrom. 2005, 40, 289-299.
15. Bolca, S., Possemiers, S., Maervoet, V., Huybrechts, I. et al., Microbial and dietary factors associated with the 8-prenylnaringenin producer phenotype: a dietary intervention trial with fifty healthy post-menopausal Caucasian women. Br. J. Nutr. 2007, 98, 950-959.
16. Possemiers, S., Bolca, S., Grootaert, C., Heyerick, A. et al., The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J. Nutr. 2006, 136, 1862-1867.
17. Zierau, O., Hauswald, S., Schwab, P., Metz, P., Vollmer, G., Two major metabolites of 8-prenylnaringenin are estrogenic in vitro. J. Steroid Biochem. Mol. Biol. 2004, 92, 107-110.
18. Williamson, G., Barron, D., Shimoi, K., Terao, J., In vitro biological properties of flavonoid conjugates found in vivo. Free Radic. Res. 2005, 39, 457-469.
19. Katzenellenbogen, J. A., OMalley, B. W., Katzenellenbogen, B. S., Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 1996, 10, 119-131.
20. Stevens, J. F., Ivancic, M., Hsu, V. L., Deinzer, M. L., Prenylflavonoids from Humulus lupulus. Phytochemistry 1997, 44, 1575-1585.
21. Nikolic, D., Li, Y., Chadwick, L. R., Grubjesic, S. et al., Metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops (Humulus lupulus), by human liver microsomes. Drug Metab. Dispos. 2004, 32, 272-279.
22. Roelens, F., Heldring, N., Dhooge, W., Bengtsson, M. et al., Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors α and β. J. Med. Chem. 2006, 49, 7357-7365.
23. Bartels, H., Bohmer, M., Eine Mikromethode zur Kreatininbestimmung. Clin. Chim. Acta 1971, 31, 81-85.
24. Bolca, S., Wyns, C., Possemiers, S., Depypere, H. et al., Cosupplementation of isoflavones, prenylflavonoids, and lignans alters human exposure to phytoestrogen-derived 17β-estradiol equivalents. J. Nutr. 2009, 139, 2293-2300.
25. Junge, W., Wilke, B., Halabi, A., Klein, G., Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaffé method. Clin. Chim. Acta 2004, 344, 137-148.
26. Chetrite, G. S., Cortes-Prieto, J., Philippe, J. C., Wright, F., Pasqualini, J. R., Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J. Steroid Biochem. Mol. Biol. 2000, 72, 23-27.
27. Dabrosin, C., Increased extracellular local levels of estradiol in normal breast in vivo during the luteal phase of the menstrual cycle. J. Endocrinol. 2005, 187, 103-108.
28. Rad, M., Hümpel, M., Schoemaker, R. C., Schleuning, W.-D. et al., Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. Br. J. Clin. Pharmacol. 2006, 62, 288-296.
29. Gerhäuser, C., Alt, A., Heiss, E., Gamal-Eldeen, A. et al., Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol. Cancer Therap. 2002, 1, 959-969.
30. Christoffel, J., Rimoldi, G., Wuttke, W., Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-months treatment. J. Endocrinol. 2006, 188, 397-405.
31. Monteiro, R., Becker, H., Azevedo, I., Calhau, C., Effect of hop (Humulus lupulus L.) flavonoids on aromatase (estrogen synthase) activity. J. Agric. Food Chem. 2006, 54, 2938-2943.
32. Monteiro, R., Faria, A., Azevedo, I., Calhau, C., Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids. J. Steroid Biochem. Mol. Biol. 2007, 105, 124-130.
33. Pepper, M. S., Hazel, S. J., Hümpel, M., Schleuning, W.-D., 8-prenylnaringenin, a novel phytoestrogen, inhibits angiogenesis in vitro and in vivo. J. Cell. Physiol. 2004, 199, 98-107.
34. Overk, C. R., Guo, J., Chadwick, L. R., Lantvit, D. D. et al., In vivo estrogenic comparisons of Trifolium pratense (red clover), Humulus lupulus (hops), and the pure compounds isoxanthohumol and 8-prenylnaringenin. Chem. Biol. Interact. 2008, 176, 30-39.
35. Gardner, C. D., Chatterjee, L. M., Franke, A. A., Effects of isoflavone supplements vs. soy foods on blood concentrations of genistein and daidzein in adults. J. Nutr. Biochem. 2009, 20, 227-234.
36. Schaefer, O., Bohlmann, R., Schleuning, W.-D., Schulze-Forster, K., Hümpel, M., Development of a radioimmunoassay for the quantitative determination of 8-prenylnaringenin in biological matrices. J. Agric. Food Chem. 2005, 53, 2881-2889.
37. Hargreaves, D. F., Potten, C. S., Harding, C., Shaw, L. E. et al., Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J. Clin. Endocrinol. Metab. 1999, 84, 4017-4024.
38. Maubach, J., Depypere, H. T., Goeman, J., Van Der Eycken, J. et al., Distribution of soy-derived phytoestrogens in human breast tissue and biological fluids. Obstet. Gynecol. 2004, 103, 892-898.
39. Nikolic, D., Li, Y., Chadwick, L. R., van Breemen, R. B., In vitro studies of intestinal permeability and hepatic and intestinal metabolism of 8-prenylnaringenin, a potent phytoestrogen form hops (Humulus lupulus L.). Pharm. Res. 2006, 23, 864-872.
40. Ruefer, C. E., Gerhäuser, C., Frank, N., Becker, H., Kulling, S. E., In vitro phase II metabolism of xanthohumol by human UDP-glucuronosyltransferases and sulfotransferases. Mol. Nutr. Food Res. 2005, 49, 851-856.
41. Yilmazer, M., Stevens, J. F., Buhler, D. R., In vitro glucuronidation of xanthohumol, a flavonoid in hop and beer, by rat and human liver microsomes. FEBS Lett. 2001, 491, 252-256.
42. Bolca, S., Urpi-Sarda, M., Blondeel, P., Roche, N. et al., Disposition of soy isoflavones in normal human breast tissue. Am. J. Clin. Nutr. 2010, 91, 976-984.
43. Doerge, D. R., Chang, H. C., Churchwell, M. I., Holder, C. L., Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab. Dispos. 2000, 28, 298-307.
44. Guy, L., Vedrine, N., Urpi-Sarda, M., Gil-Izquierdo, A. et al., Orally administered isoflavones are present as glucuronides in the human prostate. Nutr. Cancer 2008, 60, 461-468.
45. Hosoda, K., Furuta, T., Yokokawa, A., Ogura, K. et al., Plasma profiling of intact isoflavone metabolites by high-performance liquid chromatography and mass spectrometric identification of flavone glycosides daidzin and genistin in human plasma after administration of kinako. Drug Metab. Dispos. 2008, 36, 1485-1495.
46. Shelnutt, S. R., Cimino, C. O., Wiggins, P. A., Ronis, M. J. J., Badger, T. M., Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am. J. Clin. Nutr. 2002, 76, 588-594.
47. Zhang, Y., Hendrich, S., Murphy, P. A., Glucuronides are the main isoflavone metabolites in women. J. Nutr. 2003, 133, 399-404.
48. Kloosterboer, H. J., Lofgren, L., von Schoulz, E., von Schoulz, B., Verheul, H. A. M., Estrogen and tibolone metabolite levels in blood and breast tissue of postmenopausal women recently diagnosed with early-stage breast cancer and treated with tibolone or placebo for 14 days. Reprod. Sci. 2007, 14, 151-159.
49. Gustafsson, J. A., Estrogen receptor β - a new dimension in estrogen mechanism of action. J. Endocrinol. 1999, 163, 379-383.
50. Frances, B., Gout, R., Monsarrat, B., Cros, J., Zajac, J. M., Further evidence that morphine-6-β-glucuronide is a more potent opioid agonist than morphine. J. Pharmacol. Exp. Ther. 1992, 262, 477-480.
51. Zheng, Y., Sun, D., Sharma, A. K., Chen, G. et al., Elimination of antiestrogenic effects of active tamoxifen metabolites by glucuronidation. Drug Metab. Dispos. 2007, 35, 1942-1948.
52. Kinjo, J., Tsuchihashi, R., Morito, K., Hirose, T. et al., Interactions of phytoestrogens with estrogen receptors α and β (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine. Biol. Pharm. Bull. 2004, 27, 185-188.
53. Zhang, Y., Song, T. T., Cunnick, J. E., Murphy, P. A., Hendrich, S., Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. J. Nutr. 1999, 129, 399-405.
54. Prichett, L. E., Atherton, K. M., Mutch, E., Ford, D., Glucuronidation of the soyabean isoflavones genistein and daidzein by human liver is related to levels of UGT1A1 and UGT1A9 activity and alters isoflavone response in the MCF-7 human breast cancer cell line. J. Nutr. Biochem. 2008, 19, 739-745.
55. Falk, R. T., Gentzschein, E., Stanczyk, F. Z., Brinton, L. A. et al., Measurement of sex steroid hormones in breast adipocytes: methods and implications. Cancer Epidemiol. Biomarkers Prev. 2008, 17, 1891-1895.
56. O'Brien, S. N., Anandjiwala, J., Price, T. M., Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use. Obstet. Gynecol. 1997, 90, 244-248.
57. Pasqualini, J. R., Cortes-Prieto, J., Chetrite, G., Talbi, M., Ruiz, A., Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma. Int. J. Cancer 1997, 70, 639-643.
58. van Landeghem, A. A. J., Poortman, J., Nabuurs, M., Thijssen, J. H. H., Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res. 1985, 45, 2900-2906.
59. Pasqualini, J. R., Chetrite, G. S., Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J. Steroid Biochem. Mol. Biol. 2005, 93, 221-236.
60. Mathey, J., Lamothe, V., Coxam, V., Potier, M. et al., Concentrations of isoflavones in plasma and urine of post-menopausal women chronically ingesting high quantities of soy isoflavones. J. Pharm. Biomed. Anal. 2006, 41, 957-965.
61. Tsangalis, D., Wilcox, G., Shah, N. P., Stojanovska, L., Bioavailability of isoflavone phytoestrogens in postmenopausal women consuming soya milk fermented with probiotic bifidobacteria. Br. J. Nutr. 2005, 93, 867-877.
62. Albin, N., Massaad, L., Toussaint, C., Mathieu, M.-C. et al., Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Cancer Res. 1993, 53, 3541-3546.
63. Pasqualini, J. R., Chetrite, G., Blacker, C., Feinstein, M. C. et al., Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J. Clin. Endocrinol. Metab. 1996, 81, 1460-1464.
64. Li, J., Lee, L., Gong, Y., Shen, P. et al., Bioassays for estrogenic activity: development and validation of estrogen receptor (ERα/ERβ) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical trials. Assay Drug Develop. Technol. 2009, 7, 80-89.